Intense pulsed light (IPL) therapy is an effective treatment for dry eye disease (DED), especially in patients with meibomian gland dysfunction (MGD).
2
A study demonstrated that a three-session IPL regimen significantly improves tear film stability and reduces ocular surface inflammation compared to two sessions.
3
Both treatment groups showed improvements in tear film metrics, but the three-session group had superior outcomes at 12 weeks in several objective measures.
4
The study found that IPL therapy may restore immune homeostasis, as indicated by significant increases in lymphotoxin-alpha (LT-α) levels after three sessions.
5
IPL should be reconsidered as a core strategy for managing evaporative DED, rather than merely a cosmetic or supplemental treatment option.
